SCHEMBL26354926

SCHEMBL26354926

COCCn1c(C)c(Cc2cnccn2)c2c1C(=O)c1ccccc1C2=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC5 O15392 1/20 0.59
RIPK2 O43353 1/20 0.59
SP1 P08047 1/20 0.59
ILF3 Q12906 1/20 0.59
PAK1 Q13153 1/20 0.59
NOX4 Q9NPH5 1/20 0.36
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
CCND2 P30279 1/20 0.35
CCND3 P30281 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NSD2 O96028 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
GNRHR P30968 1/20 0.35
TDP1 Q9NUW8 5/20 0.34
TDP2 O95551 2/20 0.34
TSHR P16473 2/20 0.34
CYP1A2 P05177 2/20 0.34
LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sepantronium SCHEMBL2814447 0.75 BIRC5 (0.98) BIRC5RIPK2SP1ILF3PAK1
Sepantronium SCHEMBL2814857 0.75 BIRC5 (0.98) BIRC5RIPK2SP1ILF3PAK1
Sepantronium SCHEMBL29493286 0.74 BIRC5 (1.00) BIRC5RIPK2SP1ILF3PAK1
Sepantronium SCHEMBL727997 0.74 BIRC5 (1.00) BIRC5RIPK2SP1ILF3PAK1
Bromide SCHEMBL15062823 0.71 BIRC5 (0.79) BIRC5RIPK2SP1ILF3PAK1
Sepantronium SCHEMBL29464041 0.69 BIRC5 (0.71) BIRC5RIPK2SP1ILF3PAK1
Sepantronium SCHEMBL6188375 0.69 BIRC5 (0.71) BIRC5RIPK2SP1ILF3PAK1
Sepantronium SCHEMBL16584072 0.68 BIRC5 (0.73) BIRC5RIPK2SP1ILF3PAK1
Sepantronium SCHEMBL29379252 0.68 BIRC5 (0.73) BIRC5RIPK2SP1ILF3PAK1
SCHEMBL18899135 0.67 BIRC5 (0.49) BIRC5RIPK2SP1ILF3PAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230302019-A1 COMPOUND FOR TREATING AND/OR PREVENTING DISEASES CAUSED BY CORONAVIRUS AND USE THEREOF SHANGHAITECH UNIVERSITY (CN) 2023-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230302019-A1 COMPOUND FOR TREATING AND/OR PREVENTING DISEASES CAUSED BY CORONAVIRUS AND USE THEREOF SARS1, ZC3HAV1, CTH BIRC5 1913/4885RIPK2 1126/4885SP1 3645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.